Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
05/10/2007 | WO2007052937A2 Dosing regimens for cox-2 inhibitor |
05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
05/10/2007 | WO2007052837A1 Gastrointestinal function promoter |
05/10/2007 | WO2007052831A1 Preventives/remedies for urinary disturbance |
05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
05/10/2007 | WO2007052383A1 Process for producing 6,6-dimethyl-3-oxabicyclo[3.1.0]hexan-2-one |
05/10/2007 | WO2007025709A3 Organic compounds |
05/10/2007 | WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof |
05/10/2007 | WO2006085149A3 Methods and compositions for treating amyloid-related diseases |
05/10/2007 | US20070106095 Vitamin d receptor modulators |
05/10/2007 | US20070105951 non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1 alpha ,25dihydroxy vitamin D3; useful for treating bone disease and psoriasis |
05/10/2007 | US20070105946 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
05/10/2007 | US20070105933 Amino alcohol compounds |
05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
05/10/2007 | US20070105899 Benzene compounds |
05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/10/2007 | US20070105852 Thiophene and furan compounds |
05/10/2007 | US20070104709 Non-naturally occurring ligand for umami taste and sweet taste receptor; enhancing response to artificial flavoring |
05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
05/09/2007 | EP1783129A1 Spiropiperidyl rifamycins for the treatment of microbacterial infections |
05/09/2007 | EP1783121A1 Azo compounds and process for production thereof |
05/09/2007 | EP1783110A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
05/09/2007 | EP1782805A1 Composition for accelerating calcium absorption |
05/09/2007 | EP1781630A1 Novel piperidine derivative for the treatment of depression |
05/09/2007 | EP1781597A1 O-aminophenol derivatives and dyes containing these compounds |
05/09/2007 | EP1781595A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
05/09/2007 | EP1781591A1 Enantioselective synthesis of 13-oxotricyclo[8.2.1.0 3,8]trideca-3(8),4,6-triene-5-carboxylates |
05/09/2007 | EP1501816B1 Method for producing gamma-butyrolactone |
05/09/2007 | CN1960981A Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
05/09/2007 | CN1960967A Triketone-based compound, method for producing the same and herbicide containing the same |
05/09/2007 | CN1960963A Method of preparing monoesters of polyhydroxyl alcohols |
05/09/2007 | CN1960721A C7 lactyloxy-substituted taxanes |
05/09/2007 | CN1958581A Technique for processing vitamine C in low consumption |
05/09/2007 | CN1314676C Preparation of substituted phthalic anhydrides and substituted phthalimides |
05/09/2007 | CN1314660C Cinnamide compound synthesizing process |
05/09/2007 | CN1314651C Method for producing phthalic anhydride |
05/09/2007 | CN1314641C Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof |
05/08/2007 | US7214823 Forming hydroxycitric acid salts with metals such as potassium, calcium, sodium, zinc and magnesium with extraction of solutions |
05/08/2007 | US7214819 Fluorous triphasic reaction and separation processes for the generation of enantioenriched alcohols, amines, carboxylic acids and related compounds |
05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
05/08/2007 | US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
05/08/2007 | US7214641 Catalyst and hydrogenation of carbonyl compounds in the liquid phase using the catalyst |
05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
05/03/2007 | WO2007049736A1 Concentration crystallizer and method |
05/03/2007 | WO2007049295A2 An improved one pot process for making key intermediate for gemcitabine hcl |
05/03/2007 | WO2006122072A3 Processes for preparing biaryl ureas and analogs thereof |
05/03/2007 | US20070100162 Process for the liquefaction of lignocellulosic material |
05/03/2007 | US20070099991 Selective rxr ligands |
05/03/2007 | US20070099990 N-(3-(p-Isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof; cerebrovascular disorders |
05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
05/03/2007 | DE102005051325A1 Alkoxyalkyl spirocyclische Tetram- und Tetronsäuren Alkoxyalkyl spirocyclic tetramic and tetronic acids |
05/03/2007 | CA2627240A1 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
05/03/2007 | CA2627009A1 Carboxylic acid derivatives, method for the production thereof, and use thereof |
05/02/2007 | EP1780205A1 Method for producing 3-aminomethyltetrahydrofuran derivative |
05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
05/02/2007 | EP1778624A1 Tyrosine derivatives as ppar-gamma-modulators |
05/02/2007 | EP1322590B1 5-amino-1-pentene-3-ol substituted derivatives |
05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
05/02/2007 | EP0781165B2 Improved high performance vpo catalyst |
05/02/2007 | CN1956973A 2-halofuryl/thienyl-3-carboxamides |
05/02/2007 | CN1956714A Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
05/02/2007 | CN1955172A Phthalic acid derivative and use for preparing phthalamide derivative intermediate |
05/02/2007 | CN1955171A Method for preparing root of red-rooted salvia phenolic acid B |
05/02/2007 | CN1955170A Class I tanshinone II A derivative and its application in pharmaceutic |
05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
05/02/2007 | CN1955162A Phthalic acid derivative and use for preparing phthalamide derivative intermediate |
05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
05/02/2007 | CN1313470C Method for preparing N-methyl benzothiazole lifumeisu |
05/02/2007 | CN1313456C Novel method for producing methyl hexahydrobenzene anhydride |
05/02/2007 | CN1313455C Method for producing gamma-butyrolactone |
05/02/2007 | CN1313454C Method for batch extracting rectified purified tetrahydrofuran |
05/02/2007 | CN1313446C Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
05/01/2007 | US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia |
05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
05/01/2007 | CA2305458C Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity |
05/01/2007 | CA2263715C Chiral ferrocenyls |
05/01/2007 | CA2143636C Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
04/26/2007 | WO2007047447A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
04/26/2007 | WO2007047405A1 Ddc compositions |
04/26/2007 | WO2007047204A1 Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins |
04/26/2007 | WO2007046075A1 Piperazine derivatives as antimalarial agents |
04/26/2007 | WO2007045420A2 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
04/26/2007 | WO2007017267A3 Novel compounds |
04/26/2007 | WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions |
04/26/2007 | WO2006117686A3 Compounds that stimulate glucose utilization and methods of use |
04/26/2007 | US20070093548 Use of progesterone receptor modulators |
04/26/2007 | US20070093545 4-Oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof |
04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
04/26/2007 | US20070092551 Therapeutic agent |
04/26/2007 | US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers |
04/26/2007 | US20070092439 Method of preparing monoesters of polyhydroxyl alcohols |
04/26/2007 | CA2829487A1 Organic compounds |
04/26/2007 | CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
04/26/2007 | CA2625034A1 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofutran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |